First Time Loading...

Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 179.1 SEK -0.22% Market Closed
Updated: May 17, 2024
Section:
 

Relative Value

The Relative Value of one BIOT stock under the Base Case scenario is 244.98 SEK. Compared to the current market price of 179.1 SEK, Biotage AB is Undervalued by 27%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIOT Relative Value
Base Case
244.98 SEK
Undervaluation 27%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.2
P/S
P/S
Price to Sales
7.2
vs History
58
vs Industry
25
Median 3Y
7.7
Median 5Y
7.7
Industry
4
Forward
6.7
More Details
60.8
P/E
P/E
Price to Earnings
60.8
vs History
23
vs Industry
8
Median 3Y
53.4
Median 5Y
50.2
Industry
31.1
Forward
52.7
More Details
37.7
P/OCF
P/OCF
Price to OCF
37.7
vs History
44
vs Industry
12
Median 3Y
37.7
Median 5Y
36.8
Industry
23.7
More Details
62.4
P/FCFE
P/FCFE
Price to FCFE
62.4
vs History
31
vs Industry
11
Median 3Y
58.4
Median 5Y
51.2
Industry
28.7
More Details
3.7
P/B
P/B
Price to Book Value
3.7
vs History
84
vs Industry
25
Median 3Y
7.4
Median 5Y
8.6
Industry
2.6
More Details
7
EV/S
EV/S
Enterprise Value to Sales
7
vs History
60
vs Industry
25
Median 3Y
7.6
Median 5Y
7.6
Industry
3.9
Forward
6.5
More Details
11.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
11.3
vs History
63
vs Industry
31
Median 3Y
12.5
Median 5Y
12.5
Industry
8
More Details
28.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
28.1
vs History
55
vs Industry
14
Median 3Y
28.5
Median 5Y
28.9
Industry
17.5
Forward
24.3
More Details
42.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
42.5
vs History
41
vs Industry
10
Median 3Y
39.7
Median 5Y
39.7
Industry
22.8
Forward
35
More Details
36.5
EV/OCF
EV/OCF
Enterprise Value to OCF
36.5
vs History
46
vs Industry
12
Median 3Y
36.5
Median 5Y
36.4
Industry
21.9
More Details
51.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
51.8
vs History
38
vs Industry
12
Median 3Y
49.4
Median 5Y
47.5
Industry
27.9
More Details
3.2
EV/IC
EV/IC
Enterprise Value to IC
3.2
vs History
84
vs Industry
31
Median 3Y
6.3
Median 5Y
7.2
Industry
2.4
More Details

Multiples Across Competitors

BIOT Competitors Multiples
Biotage AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Biotage AB
STO:BIOT
14.4B SEK 7.2 60.8 28.1 42.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
229.1B USD 5.4 38.4 23.5 34.5
US
Danaher Corp
NYSE:DHR
195.8B USD 4.5 24.3 17.6 21.7
US
Agilent Technologies Inc
NYSE:A
45.3B USD 6.7 36.7 29.3 35.2
US
IQVIA Holdings Inc
NYSE:IQV
42.4B USD 2.8 31.2 16.9 26.2
CH
Lonza Group AG
SIX:LONN
38.1B CHF 5.7 58.2 20 29.3
KR
Samsung Biologics Co Ltd
KRX:207940
56.1T KRW 15.2 65.4 34.5 49.6
US
Mettler-Toledo International Inc
NYSE:MTD
32.5B USD 8.6 41.7 28.5 31.7
IE
ICON PLC
NASDAQ:ICLR
26B USD 3.2 38 17.2 26.4
US
West Pharmaceutical Services Inc
NYSE:WST
25.6B USD 8.8 45.1 31.3 37.9
US
Waters Corp
NYSE:WAT
21.3B USD 7.3 35.4 23.7 29.2

See Also

Summary
BIOT intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIOT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIOT stock valuation using valuation multiples.
Wall Street Estimates
BIOT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIOT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.